Has Deborah Johnson received payments from drug or device companies?

Yes. Drug and device makers reported $7,556 in general payments to Deborah Johnson across 290 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Deborah Johnson did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Deborah Johnson come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Deborah Johnson

Psychiatric/Mental Health · Oakland, CANPI 1518270388

Payments from drug & device makers

$7,556in general payments, 2019–2025

Across 290 payments — averaging $26.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$2K
Bausch Health US, LLC$874
Axsome Therapeutics, Inc.$825
Johnson & Johnson$766
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$504
Vanda Pharmaceuticals Inc.$392
plus $3K from 17 others

What the payments were for

Food & beverage$7,556100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie	103	$1,549
Bausch Health US, LLC	43	$874
Axsome Therapeutics, Inc.	16	$825
Johnson & Johnson	14	$766
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	14	$504
Vanda Pharmaceuticals Inc.	8	$392
Lundbeck LLC	18	$358
Neurocrine Biosciences, Inc.	6	$353
E.r. Squibb & Sons, L.L.C.	7	$319
Alkermes, Inc.	12	$261
Teva Pharmaceuticals USA, Inc.	4	$228
Takeda Pharmaceuticals U.S.A., Inc.	11	$218
Eisai Inc.	3	$163
Ironshore Pharmaceuticals Inc.	7	$149
Sunovion Pharmaceuticals Inc.	6	$141
Otsuka America Pharmaceutical, Inc.	5	$100
Sanofi-aventis U.S. LLC	1	$100
Supernus Pharmaceuticals, Inc.	3	$62
Idorsia Pharmaceuticals US Inc	2	$47
Collegium Pharmaceutical, Inc.	2	$46
Otsuka Pharmaceutical Development & Commercialization, Inc.	1	$39
Tris Pharma Inc	2	$38
Corium, LLC	2	$27

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,556 in reported general payments places this provider in the 95th percentile of 2,433 psychiatric/mental health providers in California.

See all psychiatric/mental health providers in California →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Aripiprazole	25	$1,398
Lamotrigine	13	$294
Methylphenidate Hcl	13	$229
Fluoxetine Hcl	16	$79

Paid to pharmacies, not to this prescriber.

Other psychiatric/mental health in Oakland

Carey MartinMillbrae$745K
Liberty MaciasRedlands$288K
Joshua BurgettSacramento$239K
Jovita Ezirim-SalamialofojeLos Angeles$162K
Angie-Kolleen TanThousand Oaks$159K
Thy LamVista$121K
David OhIrvine$72K
Samantha PerkinsAnaheim$49K
Yvette ElpidioOrange$43K
Sarah KoLos Angeles$34K

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →